Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Ltd. ( (AU:OSX) ) has provided an announcement.
Osteopore Limited has issued a cleansing notice in connection with a new tranche of redeemable convertible notes subscribed by Cayman Islands-based Advance Opportunities funds. The Second T2 Convertible Notes, representing a subsequent $250,000 investment under a broader $20 million subscription agreement, will be issued today and can convert into fully paid ordinary shares that may be on-sold to retail investors without further disclosure.
The fresh tranche will increase Osteopore’s cash reserves by up to $250,000 before costs, providing additional working capital as the company advances its growth plans. By structuring the funding through convertible notes and ensuring secondary trading eligibility via the cleansing notice, Osteopore maintains access to flexible capital while supporting liquidity in its shares for existing and prospective investors.
The most recent analyst rating on (AU:OSX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Ltd is a medical technology company focused on regenerative bone and tissue solutions. The company develops and commercialises bioresorbable, 3D-printed scaffolds designed to facilitate natural bone healing, targeting applications in craniofacial, orthopaedic and dental surgery across global healthcare markets.
Average Trading Volume: 31,878,288
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.5M
Find detailed analytics on OSX stock on TipRanks’ Stock Analysis page.